Search form

Prodesse Pro hMPV+ Assay

The Prodesse Plus series of respiratory assays can be used alone or in combination with each other, offering flexibility and control over your molecular respiratory test menu and the ability to personalize patient testing.

The Prodesse Pro hMPV+ assay is for the detection of human metapneumovirus (hMPV).

 

 

 

 

 

About

The Prodesse Pro hMPV+ assay is a real-time PCR (RT-PCR) in vitro diagnostic test for the qualitative detection of human metapneumovirus (hMPV) nucleic acid isolated and purified from nasopharyngeal swab (NP) specimens obtained from individuals exhibiting signs and symptoms of acute respiratory infection.

Discovered in 2001 by Dutch researchers, hMPV causes symptoms similar to respiratory syncytial virus (RSV)and many other respiratory viruses. Originally considered primarily a pediatric pathogen, studies show hMPV can occur in all ages. Particularly at risk are pediatric, elderly and immuno-compromised patients. It is responsible for a significant portion of the children hospitalized every year for bronchiolitis.

The Prodesse Pro hMPV+ assay offers laboratories, clinicians and their patients an important tool for the diagnosis and differentiation of viral respiratory disease, delivering:

Results in as little as 4 hours

Like all of the Prodesse product line assays, the Pro hMPV+ assay uses proven real-time PCR technology, ensuring that accurate test results are delivered quickly and easily. The test's compatibility with automated nucleic-acid extraction technology minimizes hands-on time and expedites results. 

 Easy to implement in the lab

Designed to run on standard molecular diagnostic equipment, the Pro hMPV+ assay has a simple workflow that makes it easy to implement and validate. A universal internal control allows a single nucleic-acid extract to be used in any combination of Prodesse respiratory virus assays.

Performance Data

Pro hMPV+

 

 

Composite Reference Methods

 

 

 

Positive

Negative

Total

Comments

Positive

64

8

72

Percent Positive Agreement 95.5%
(87.6% - 98.5%) 95% CI

Negative

3

1200

1203

Percent Negative Agreement 99.3%
(98.7% - 99.7%)  95% CI

Total

67

1208

1275

 

 

 

Please see package insert for detailed information. 

Regulatory

The Prodesse Pro hMPV+ assay was cleared for in vitro diagnostic use by the FDA in 2008.

For additional availability in other countries beyond the U.S., please contact your local sales representative or distributor.